Global Huntington’s Disease Therapeutics Market Report 2021: Market to Reach $3.1 Billion by 2027 – U.S. Market is Estimated at $107.7 Million, While China is Forecast to Grow at 41.6% CAGR – ResearchAndMarkets.com

Global Huntington’s Disease Therapeutics Market Report 2021: Market to Reach $3.1 Billion by 2027 – U.S. Market is Estimated at $107.7 Million, While China is Forecast to Grow at 41.6% CAGR – ResearchAndMarkets.com




Global Huntington’s Disease Therapeutics Market Report 2021: Market to Reach $3.1 Billion by 2027 – U.S. Market is Estimated at $107.7 Million, While China is Forecast to Grow at 41.6% CAGR – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Huntington’s Disease Therapeutics – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Global Huntington’s Disease Therapeutics Market to Reach $3.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Huntington’s Disease Therapeutics estimated at US$402.2 Million in the year 2020, is projected to reach a revised size of US$3.1 Billion by 2027, growing at a CAGR of 33.7% over the period 2020-2027.

The U.S. Market is Estimated at $107.7 Million, While China is Forecast to Grow at 41.6% CAGR

The Huntington’s Disease Therapeutics market in the U.S. is estimated at US$107.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$821 Million by the year 2027 trailing a CAGR of 41.6% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 26.9% and 30.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 28.9% CAGR.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS (Total 25 Featured):

  • Alnylam Pharmaceuticals, Inc.
  • Evotec AG
  • GlaxoSmithKline PLC
  • Horizon Therapeutics plc
  • Ionis Pharmaceuticals, Inc.
  • Raptor Pharmaceutical Corporation
  • Sangamo Biosciences, Inc.
  • Suven Life Sciences Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Vertex Pharmaceuticals Inc.
  • Wave Life Sciences Ltd.

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • World Current & Future Analysis for Huntington’s Disease Therapeutics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • World Historic Review for Huntington’s Disease Therapeutics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • World 15-Year Perspective for Huntington’s Disease Therapeutics by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • United States
  • Canada
  • Japan
  • China
  • Europe
  • France
  • Germany
  • Italy
  • United Kingdom
  • Spain
  • Russia
  • Rest of Europe
  • Asia-Pacific
  • Australia
  • India
  • South Korea
  • Rest Of Asia-Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East
  • Iran
  • Israel
  • Saudi Arabia
  • United Arab Emirates
  • Rest of Middle East
  • Africa

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/wiwg4x

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900